TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24708031

Group type: COMPARATOR
Intervention: Tiotropium (18 μg once daily)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Indacaterol (150 μg once daily)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Tiotropium plus Indacaterol (combined therapy)
Number of subjects: 54
Study: 23000116

Group type: EXPERIMENTAL
Intervention: Intervention (annual prostate-specific antigen for 6 years and digital rectal exam for 4 years)
Number of subjects: 76693

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 76693

Group type: EXPERIMENTAL
Intervention: Intervention (within the intervention arm)
Number of subjects: 76693

Group type: EXPERIMENTAL
Intervention: All PLCO cases
Number of subjects: 76693

Group type: EXPERIMENTAL
Intervention: Gleason 5‐7 cases
Number of subjects: 76693

Group type: EXPERIMENTAL
Intervention: Gleason 8‐10 cases
Number of subjects: 76693
Study: 20518086

Group type: EXPERIMENTAL
Intervention: Viusid (3 sachets daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19023825

Group type: EXPERIMENTAL
Intervention: Brief tobacco cessation intervention with fax referral to Quitline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care Control
Number of subjects: 0
Study: 15739653

Group type: EXPERIMENTAL
Intervention: UlcerCare leg wrap (treatment)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham non‐magnetic device (control)
Number of subjects: 26
Study: 12449022

Group type: EXPERIMENTAL
Intervention: Coltosol
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IRM
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Scotch Bond
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no barrier material)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vidrion R
Number of subjects: 100
Study: 10614952

Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin 200 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin 400 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin 500 mg
Number of subjects: 12
Study: 8602779

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 8

Group type: COMPARATOR
Intervention: No cryotherapy (control)
Number of subjects: 8
Study: 8458192

Group type: EXPERIMENTAL
Intervention: Acipimox
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 16
Study: 3529803

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (Healon) used during anterior capsulotomy and lens implantation, aspirated at the end of surgery (Group I)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (Healon) + 500 mg acetazolamide at the end of surgery (Group II)
Number of subjects: 69

Group type: COMPARATOR
Intervention: BSS and/or air used instead of Healon during surgery (Group III)
Number of subjects: 69
Study: 31177885

Group type: EXPERIMENTAL
Intervention: Anodal (excitatory) tDCS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study: 28552274

Group type: EXPERIMENTAL
Intervention: Hemostatic gelatin sponge
Number of subjects: 76

Group type: COMPARATOR
Intervention: Polyvinyl acetate
Number of subjects: 76

Group type: COMPARATOR
Intervention: Both packs
Number of subjects: 76

Group type: COMPARATOR
Intervention: Cost of the pack
Number of subjects: 76

Group type: COMPARATOR
Intervention: Wound healing
Number of subjects: 76
Study: 27231096

Group type: EXPERIMENTAL
Intervention: Rested condition
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sleep-deprived condition
Number of subjects: 16
Study: 25744780

Group type: EXPERIMENTAL
Intervention: About Eating (AE) program
Number of subjects: 288
Study: 24505906

Group type: EXPERIMENTAL
Intervention: Local periprostatic anesthesia with 10 ml of lidocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: No local anesthesia
Number of subjects: 100
Study: 21781338

Group type: EXPERIMENTAL
Intervention: Computer reminders (ComRem)
Number of subjects: 739

Group type: COMPARATOR
Intervention: Postal reminder letters
Number of subjects: 739

Group type: COMPARATOR
Intervention: Usual activities (no reminders)
Number of subjects: 739
Study: 18085514

Group type: EXPERIMENTAL
Intervention: Grape juice and wine extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Grape juice extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16606959

Group type: EXPERIMENTAL
Intervention: Planned cesarean section
Number of subjects: 0

Group type: COMPARATOR
Intervention: Planned vaginal birth
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Planned cesarean section (first birth)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Planned vaginal birth (first birth)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Planned cesarean section (prior birth)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Planned vaginal birth (prior birth)
Number of subjects: 0
Study: 12955409

Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine 16 microg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine 24 microg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine 32 microg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine 40 microg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine doses >16 microg
Number of subjects: 36
Study: 11224966

Group type: EXPERIMENTAL
Intervention: 30 minutes of moderate intensity exercise (brisk walking or equivalent) five days per week for six weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group maintaining existing levels of physical activity
Number of subjects: 0
Study: 7747361

Group type: EXPERIMENTAL
Intervention: Electrovesicography (EVG) in interstitial cystitis patients
Number of subjects: 9

Group type: COMPARATOR
Intervention: Electrovesicography (EVG) in healthy women (control group)
Number of subjects: 9
Study: 2402051

Group type: EXPERIMENTAL
Intervention: Taurine supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholesterol supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Formula without supplements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breastfed infants
Number of subjects: 0
Study: 7225481

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (Li)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30940201

Group type: EXPERIMENTAL
Intervention: Tamponade dressing after hemorrhoidectomy
Number of subjects: 953

Group type: COMPARATOR
Intervention: No tamponade dressing after hemorrhoidectomy
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: Postoperative analgesics use
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: Lowest hemoglobin documented within 7 days
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: Quality of life and patient satisfaction
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: Adverse and serious adverse events
Number of subjects: 953
Study: 28335624

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT) - 16 sessions of 50 minutes each
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Escitalopram - 10-20 mg/day for 12 weeks
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Duloxetine - 30-60 mg/day for 12 weeks
Number of subjects: 344
Study: 26250060

Group type: EXPERIMENTAL
Intervention: Systemic amoxicillin 500 mg plus metronidazole 400 mg (3x/day, 7 days)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406
Study: 23724548

Group type: EXPERIMENTAL
Intervention: Mini fiber‐reinforced composite (FRC) pins in Group C
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metal dentin pins in Group B
Number of subjects: 30

Group type: COMPARATOR
Intervention: No pins (Group A)
Number of subjects: 30
Study: 21707564

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia using remifentanil (25-30 μg per bolus)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Intramuscular pethidine (50-75 mg)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia using remifentanil
Number of subjects: 69

Group type: COMPARATOR
Intervention: Intramuscular pethidine
Number of subjects: 69
Study: 19621718

Group type: EXPERIMENTAL
Intervention: IL-2 at 9 million IU/day for 3 days before surgery (Group A)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: IL-2 at 12 million IU/day for 3 days before surgery (Group B)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Surgery alone (Group C)
Number of subjects: 31
Study: 16439428

Group type: EXPERIMENTAL
Intervention: Allopurinol (acute administration)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Older subjects
Number of subjects: 18

Group type: COMPARATOR
Intervention: Young subjects
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Older and young subjects
Number of subjects: 18
Study: 15369615

Group type: EXPERIMENTAL
Intervention: Soy and isoflavone intakes measured by FFQ
Number of subjects: 1823

Group type: EXPERIMENTAL
Intervention: FFQ assessment of soy food consumption
Number of subjects: 1823

Group type: COMPARATOR
Intervention: Stratified analyses in case and control groups
Number of subjects: 1823
Study: 11519480

Group type: EXPERIMENTAL
Intervention: JC virus type 2 detected in CSF samples
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Dual infection with JC virus types 1 and 2
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: JC virus DNA detection in CSF
Number of subjects: 52

Group type: COMPARATOR
Intervention: JC virus DNA detection in PBMCs and urine
Number of subjects: 52
Study: 9266781

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 7670422

Group type: EXPERIMENTAL
Intervention: Nocturnal bruxers who reported pain
Number of subjects: 80

Group type: COMPARATOR
Intervention: Myofascial pain patients
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bruxers
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Myofascial pain
Number of subjects: 80
Study: 2851654

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sodium restriction
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination of low sodium intake and enalapril
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31621255

Group type: EXPERIMENTAL
Intervention: Wrist-ankle needle combined with opioid drugs
Number of subjects: 60
Study: 28489798

Group type: EXPERIMENTAL
Intervention: Functional microarray of microneedles plus topical 0.5% tranexamic acid solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham device plus topical 0.5% tranexamic acid solution
Number of subjects: 30
Study: 26188890

Group type: EXPERIMENTAL
Intervention: HAM preserved in glycerol 98%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vaseline gauze
Number of subjects: 40
Study: 24495682

Group type: EXPERIMENTAL
Intervention: Intradermal injection group, administered via bilateral forearm intradermal injections for immunotherapy once every 21 days, measured after 2, 3, 4, and 5 times of injections.
Number of subjects: 326

Group type: COMPARATOR
Intervention: Subcutaneous injection group, administered via subcutaneous injection once every 21 days, measured after 3 times.
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Both groups after blocking antibody turning positive.
Number of subjects: 326
Study: 21161814

Group type: EXPERIMENTAL
Intervention: Educational flyer
Number of subjects: 411

Group type: COMPARATOR
Intervention: Comparison group (posttest only)
Number of subjects: 411
Study: 19205272

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 microg initial dose followed by up to 1200 microg if needed)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral misoprostol (400 microg initial dose followed by up to 1200 microg if needed)
Number of subjects: 60
Study: 17042841

Group type: EXPERIMENTAL
Intervention: Anterior jaw lift manoeuvre
Number of subjects: 50

Group type: COMPARATOR
Intervention: Berman airway
Number of subjects: 50
Study: 14558631

Group type: EXPERIMENTAL
Intervention: Electronic diary for home monitoring
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard telephone reporting procedures
Number of subjects: 119
Study: 11015982

Group type: EXPERIMENTAL
Intervention: Balloon sampler
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Sponge sampler
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Sponge-mesh sampler
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: All three samplers
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Encapsulated samplers (sponge and sponge-mesh)
Number of subjects: 62
Study: 8714631

Group type: EXPERIMENTAL
Intervention: Illusory contours defined by orthogonal lines with a clear gap or overlap
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Illusory contours made up of abutting lines without gap or overlap
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disparity in illusory borders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contours with uniform space-averaged luminance
Number of subjects: 0
Study: 1433118

Group type: EXPERIMENTAL
Intervention: Ceftazidime (CAZ) monotherapy
Number of subjects: 471

Group type: COMPARATOR
Intervention: Aminoglycoside+(ureido)penicillin combination (AG+PEN)
Number of subjects: 471
Study: 3894199

Group type: COMPARATOR
Intervention: Sengstaken‐Blakemore tube
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerosis
Number of subjects: 43
Study: 29779672

Group type: EXPERIMENTAL
Intervention: Obesity (measured by body mass index)
Number of subjects: 149683

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 149683

Group type: EXPERIMENTAL
Intervention: Smoking (in pack‐years)
Number of subjects: 149683

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 149683

Group type: EXPERIMENTAL
Intervention: Age (nonmodifiable risk factor)
Number of subjects: 149683
Study: 27815185

Group type: EXPERIMENTAL
Intervention: Ileostomy reversal
Number of subjects: 118
Study: 25305763

Group type: COMPARATOR
Intervention: Pulsed Dye Laser (PDL)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Pulsed Dye Laser (PDL) plus topical propranolol
Number of subjects: 19
Study: 22266107

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Non-contact control group
Number of subjects: 18
Study: 20832381

Group type: EXPERIMENTAL
Intervention: Calcium phosphate wedge (BMCaPh group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Autologous tricortical graft (AUTO group)
Number of subjects: 40
Study: 17710719

Group type: EXPERIMENTAL
Intervention: Straight road
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Winding road
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Mixed route
Number of subjects: 26
Study: 15834546

Group type: EXPERIMENTAL
Intervention: Frequency-modulated electromagnetic neural stimulation (FREMS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 11932272

Group type: EXPERIMENTAL
Intervention: Micronized E2 (2 mg/d) plus standard-dose alendronate (10 mg/d)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Micronized E2 plus low-dose alendronate (5 mg/d)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Micronized E2 plus placebo (one tablet per day)
Number of subjects: 150
Study: 10374427

Group type: EXPERIMENTAL
Intervention: HpPro 7.5 mg orally three times daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mixture of known drugs (control)
Number of subjects: 20
Study: 7638426

Group type: EXPERIMENTAL
Intervention: Teaching approach of one hour on the respiratory physiology of the CHS and on breathing techniques; n = 5
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Teaching approach with breathing retraining of 8 sessions; n = 8
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Teaching approach with breathing retraining of 8 sessions and modified Jacobson's progressive relaxation; n = 5
Number of subjects: 18
Study: 2696324

Group type: EXPERIMENTAL
Intervention: Hinged cast-brace
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cylinder plaster cast
Number of subjects: 32
Study: 50681

Group type: EXPERIMENTAL
Intervention: Placental gamma-globulin administered at a dose of 3 ml
Number of subjects: 32120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32120
Study: 31533256

Group type: EXPERIMENTAL
Intervention: Nutri-Score (NS)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Multiple Traffic Lights (MTL)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control (no label)
Number of subjects: 154
Study: 27272538

Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST-IT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Active control group (alternative general activities)
Number of subjects: 39
Study: 25728933

Group type: EXPERIMENTAL
Intervention: 4F-PCC
Number of subjects: 181

Group type: COMPARATOR
Intervention: Plasma
Number of subjects: 181
Study: 22496329

Group type: EXPERIMENTAL
Intervention: OC000459 (200 mg twice daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: OC000459
Number of subjects: 16
Study: 21600524

Group type: EXPERIMENTAL
Intervention: Mediterranean-style low-glycemic-load diet plus medical food (phytosterols, soy protein, hops and acacia extracts)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Mediterranean-style low-glycemic-load diet (control arm)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Medical food intake (part of intervention)
Number of subjects: 89
Study: 19476729

Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 27
Study: 16882708

Group type: EXPERIMENTAL
Intervention: 20 mg/m2 intravenously daily for 5 days
Number of subjects: 95

Group type: COMPARATOR
Intervention: 20 mg/m2 subcutaneously daily for 5 days
Number of subjects: 95

Group type: COMPARATOR
Intervention: 10 mg/m2 intravenously daily for 10 days
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 5-day intravenous schedule
Number of subjects: 95
Study: 17147754

Group type: EXPERIMENTAL
Intervention: Pragmatic randomised controlled trials
Number of subjects: 0
Study: 11288772

Group type: EXPERIMENTAL
Intervention: Bupropion sustained release (SR)
Number of subjects: 24
Study: 9449019

Group type: EXPERIMENTAL
Intervention: Alcohol 0.45 g/lbw
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Alcohol 0.15 g/lbw
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Alcohol 0.30 g/lbw
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 8198936

Group type: EXPERIMENTAL
Intervention: Imidapril 10 mg
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Imidapril 20 mg
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Imidapril 40 mg
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Imidapril 2.5 mg
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Imidapril 5 mg
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 3122546

Group type: EXPERIMENTAL
Intervention: Propranolol (up to 320 mg per day)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nifedipine (up to 120 mg per day)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Propranolol or Nifedipine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sublingual nitroglycerin therapy (control)
Number of subjects: 15
Study: 28830699

Group type: EXPERIMENTAL
Intervention: Simple dietary advice using a uniform pamphlet
Number of subjects: 70

Group type: COMPARATOR
Intervention: Denture care advice (Control)
Number of subjects: 70
Study: 27334070

Group type: EXPERIMENTAL
Intervention: 2800 IU of vitamin D per day for 8 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 24705022

Group type: EXPERIMENTAL
Intervention: ALICE app for 3 months
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: ALICE app for patients with initially higher rate of medication errors
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: ALICE app for patients with no experience with information and communication technologies
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: ALICE app satisfaction
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: ALICE app perceived independence
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (oral and written information on safe medication use)
Number of subjects: 99
Study: 22579007

Group type: EXPERIMENTAL
Intervention: AMC/DCBA + lidocaine lozenge
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Hexylresorcinol lozenge
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 190
Study: 20190840

Group type: EXPERIMENTAL
Intervention: liposomal amphotericin B
Number of subjects: 99

Group type: COMPARATOR
Intervention: no intervention
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: PCR tests for Aspergillus after day 100
Number of subjects: 99
Study: 18932286

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) therapy combined with Western medicine
Number of subjects: 145

Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 145
Study: 16211732

Group type: COMPARATOR
Intervention: succinylcholine 1.0 mg kg[‐1]
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: rocuronium 0.6 mg kg[‐1]
Number of subjects: 222
Study: 11930969

Group type: EXPERIMENTAL
Intervention: Intervention group (social skills and anger-control training, academic tutoring, parent training, home visiting)
Number of subjects: 891

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 891
Study: 10818662

Group type: EXPERIMENTAL
Intervention: Treatment of male partners of women with bacterial vaginosis
Number of subjects: 0
Study: 7722117

Group type: EXPERIMENTAL
Intervention: Heart failure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ejection fraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heart failure and ejection fraction
Number of subjects: 0
Study: 1961650

Group type: EXPERIMENTAL
Intervention: Modified grid laser photocoagulation
Number of subjects: 185
Study: 7049512

Group type: EXPERIMENTAL
Intervention: Bicycle exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control study (non-exercise)
Number of subjects: 0
Study: 31675385

Group type: EXPERIMENTAL
Intervention: Probable UTI (n = 13 participants)
Number of subjects: 1061

Group type: COMPARATOR
Intervention: Normal urinalysis (n = 387 participants)
Number of subjects: 1061